Effect of a "handshake" stewardship program versus a formulary restriction policy on High-End antibiotic use, expenditure, antibiotic resistance, and patient outcome.
Anti-Bacterial Agents
/ administration & dosage
Antimicrobial Stewardship
/ organization & administration
Bacteremia
/ epidemiology
Cross Infection
/ epidemiology
Drug Costs
/ statistics & numerical data
Drug Resistance, Microbial
Gram-Negative Bacteria
/ drug effects
Hospital Mortality
/ trends
Humans
Imipenem
/ economics
Interrupted Time Series Analysis
Lebanon
Length of Stay
/ statistics & numerical data
Meropenem
/ economics
Patient Readmission
/ statistics & numerical data
Policy
Retrospective Studies
Treatment Outcome
7-day readmission rate;
Handshake antibiotic stewardship;
Lebanon
antibiotic consumption;
carbapenem-resistant Gram-negative bacteria;
expenditure;
length of stay;
mortality
nosocomial bacteremia;
patient outcome;
prospective audit and feedback;
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
pubmed:
5
5
2020
medline:
19
8
2021
entrez:
5
5
2020
Statut:
ppublish
Résumé
This study reports the effect of implementing an antibiotic stewardship program (ASP) based on the "handshake" strategy for 2 years on multiple endpoints compared with that in a preceding period when an antimicrobial restriction policy was only applied in the absence of a complete program in a tertiary-care Lebanese hospital. The studied endpoints were broad-spectrum antibiotic consumption, antibiotic expenditure, nosocomial bacteremia incidence rate, and patient outcome.An interrupted time series analysis was undertaken to assess the changes in the trend (ΔT) and level (ΔL) of the aforementioned endpoints among adult inpatients before (October 2013 to September 2015) and after the introduction of the ASP (October 2016 to September 2018).After the implementation of the "handshake" ASP, marked changes were observed in the consumption of broad-spectrum antibiotics. The mean use density levels for imipenem and meropenem decreased by 13.72% (
Identifiants
pubmed: 32364030
doi: 10.1080/1120009X.2020.1755589
doi:
Substances chimiques
Anti-Bacterial Agents
0
Imipenem
71OTZ9ZE0A
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM